ZIM
PGNX

Zacks Investment Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Zacks Investment Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-21,322
Closed -$145K – 690
2017
Q2 		$145K Buy
+21,322
New +$145K ﹤0.01% 560
2014
Q3 		– Sell
-77,322
Closed -$333K – 775
2014
Q2 		$333K Buy
+77,322
New +$333K 0.01% 544